In terms of growth, the market began to show signs of improvement in 2012, overall market value has still not recovered from the recession, currently standing at around the same levels as 2002.
written on 30.07.2014
The impact of austerity on Portugal’s market growth and value
Similar Facts and Figures
Top 20 Pharma Companies in Portugal Ranking
The top 20 pharma companies in Portugal ranked by sales and market share for the year leading up to March 2018. MSD leads the way with EUR 148 million in…
Portugal’s top 20 pharma companies by sales, September 2013
Showing figures for September 2013, this table lists the top 20 pharma companies in the Portuguese market, based on sales.
Portugal / Medical Cannabis Exports Up 63%, On Track to Become a Key Global Player
Portugal’s strong legal framework along with its low production costs and strategic location within Europe have given rise to a thriving medicinal cannabis sector. With exports in 2022 that surpassed…
Portugal / 5 Healthcare & Pharma Facts to Know
One of Europe’s smaller nations and its westernmost, Portugal, with a pharma market worth roughly USD 3.5 billion, may not be known as the continent’s pharma powerhouse. Yet the country…
Europe / Sustainability & Pharma Procurement: Are You ‘Green’ Enough?
In the wake of the 2021 United Nations Climate Change Conference (COP26), sustainability is once more a hot-button issue across all industries, including pharma. Here, Marco Rauland, vice president global…